Search results
Results from the WOW.Com Content Network
Cencora, Inc., formerly known as AmerisourceBergen, is an American drug wholesale company and a contract research organization that was formed by the merger of Bergen Brunswig and AmeriSource in 2001.
x. AOL works best with the latest versions of the browsers. You're using an outdated or unsupported browser and some AOL features may not work properly.
Language links are at the top of the page. Search. Search
This page was last edited on 31 August 2023, at 09:27 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike License 4.0; additional terms may ...
AmerisourceBergen now expects 2023 adjusted earnings in the range of $11.85 to $11.95 per share, compared with its prior forecast of $11.70 to $11.90 per share. Analysts were expecting an annual ...
You can find instant answers on our AOL Mail help page. Should you need additional assistance we have experts available around the clock at 800-730-2563.
1961 or 1962 (age 62–63) [1] South Africa. Title. Chairman, president and CEO, AmerisourceBergen. Predecessor. R. David Yost. Successor. incumbent. Steven H. Collis (born 1961) is an American businessman, the chairman, president and chief executive officer (CEO) of Cencora, previously known as AmerisourceBergen. [2][3][4][5]
AmerisourceBergen's service solutions range from niche premium logistics and pharmaceutical packaging to reimbursement and pharmaceutical consulting services. With nearly $80 billion in annual ...